NASDAQ: INVA - Innoviva, Inc.

Yield per half year: +38.01%
Sector: Healthcare

Current price: 19.97 $
Average price: 27.38 $

Price based on EPS: 21.33 $ +6.82%
Price according to DCF model (FCF): 28.14 $ +40.91%
Discount price Net Income: 22.07 $ +10.51%
10/10

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 21.33 $
Current price = 19.97 $ (difference = +6.82%)


Data

Discounted Cash Flow (Based on EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 37.97 $
Current price = 19.97 $ (difference = +90.13%)


Data

Discounted Cash Flow (Based on FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 28.14 $
Current price = 19.97 $ (difference = +40.91%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription